Dactylone inhibits epidermal growth factor-induced transformation and phenotype expression of human cancer cells and induces G1-S arrest and apoptosis

Cancer Research

Volumn 67, Issue 12, 2007, Pages 5914-5920

  Fedorov, Sergey N ^a   Shubina, Larisa K ^b   Bode, Ann M ^b   Stonik, Valentin A ^b   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; CYCLIN DEPENDENT KINASE 4; DACTYLONE; EPIDERMAL GROWTH FACTOR; PROTEIN P53; SESQUITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PREVENTION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; COLON TUMOR; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; LUNG TUMOR; MELANOMA; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; FLOW CYTOMETRY; G1 PHASE; HUMANS; MICE; NEOPLASMS; PHENOTYPE; S PHASE; SESQUITERPENES; TRANSFECTION;

EID: 34250852375     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-3723     Document Type: Article

References (44)

1. Sauer LA, Dauchy RT, Blask DE. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res 2000;60:5289-95.
2. Martin JD, Darias J. Algal sesquiterpenoids. In: Scheuer PJ, Darias J, editors. Marine natural products, chemical and biological perspectives. New York: Academic Press; 1978. p. 125-73.
3. Fraga BM. Natural sesquiterpenoids. Nat Prod Rep 2005;22:465-86.
4. Lyakhova EG, Fedorov SN, Shubina LK. Chemical properties of marine terpenoids I. Some reactions of (6S ,10R)-10-bromo-3,11,11-trimethyl-7- methylidenespiro[5,5] undec-2-en-4-one, a sesquiterpenoid from the sea hare, Aplysia dactylomela. Russ Chem Bull 2003;52:1022-6.
5. Fedorov SN, Reshetnyak MV, Schedrin AP. New halogenated chamigrane sesquiterpenoid from the mollusk, Aplysia sp. Structure and absolute configuration. Dok1 AN SSSR1989;305 :877-9.
6. Fedorov SN, Shubina LK, Kalinovsky AI, et al. Structure and absolute configuration of a new rearranged chamigrane-type sesquiterpenoid from the sea hare Aplysia sp. Tetrahedron Lett 2000;41:1979-82.
7. Fedorov SN, Radchenko OS, Shubina LK, et al. Aplydactone, a new sesquiterpenoid with an unprecedented carbon skeleton from the sea hare Aplysia dactylomela, and its cargill-like rearrangement. J Am Chem Soc 2001;123:504-5.
8. Suzuki M, Kurosawa E, Irie T. Three new sesquiterpenoids containing bromine, minor constituents of Laurencia glandulifera Kutzing. Tetrahedron Lett 1974;15:821-4.
9. Fedorov SN, Bode AM, Stonik VA, et al. Marine alkaloid polycarpine and its synthetic derivative dimethylpolycarpine induce apoptosis in JB6 cells through p53- and caspase 3-dependent pathways. Pharm Res 2004;21:2307-19.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
11. Colburn NH, Former BF, Nelson KA, et al. Tumour promoter induces anchorage independence irreversibly. Nature 1979;281:589-91.
12. Colburn NH, Wendel EJ, Abruzzo G. Dissociation of mitogenesis and late-stage promotion of tumor cell phenotype by phorbol esters: mitogen-resistant variants are sensitive to promotion. Proc Natl Acad Sci U S A 1981;78:6912-6.
13. Dong Z, Cmarik JL, Wendel EJ, et al. Differential transformation efficiency but not AP-1 induction under anchorage-dependent and -independent conditions. Carcinogenesis 1994;15:1001-4.
14. Dong Z, Birrer MJ, Watts RG, et al. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci U S A 1994;91:609-13.
15. Dong Z, Watts SG, Sun Y, et al. Progressive elevation of AP-1 activity during preneoplastic-to neoplastic progression as modeled in mouse JB6 cell variants. Int J Oncol 1995;7:359-64.
16. Dong Z, Lavrovsky V, Colburn NH. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 1995;16:749-56.
17. Dong Z, Cmarik JL. Harvesting cells under anchorage-independent cell transformation conditions for biochemical analyses. Sci STKE 2002;2002:PL7.
18. Lavrovsky V, Dong Z, Ma WY, et al. Drug-induced reversion of progression phenotype is accompanied by reversion of AP-1 phenotype in JB6 cells. In Vitro Cell Dev Biol Anim 1996;32:234-7.
19. Strickland J, Sun Y, Dong Z, et al. Grafting assay distinguishes promotion sensitive from promotion resistant JB6 cells. Carcinogenesis 1997;18:1135-8.
20. Sun Y, Nakamura K, Hegamyer G, et al. No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants. Mol Carcinog 1993;8:49-57.
21. Alblas J, Slager-Davidov R, Steenbergh PH, et al. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells. Oncogene 1998;16:131-9.
22. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-85.
23. Pumiglia KM, Decker SJ. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci U S A 1997;94:448-52.
24. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-69.
25. Mousa SS, Mousa SA. Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 2005;52:59-65.
26. Saha P, Banerjee S, Ganguly C, et al. Black tea extract can modulate protein expression of H-ras, c-Myc, p53, and Bcl-2 genes during pulmonary hyperplasia, dysplasia, and carcinoma in situ. J Environ Pathol Toxicol Oncol 2005;24:211-24.
27. Mayhew CN, Perkin LM, Zang X, et al. Discrete signaling pathways participate in Rb-dependent responses to chemotherapeutic agents. Oncogene 2004;23:4107-20.
28. Classon M, Harlow E. The retinoblastoma tumor suppressor in development and cancer. Nat Rev Cancer 2002;2:910-7.
29. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
30. Hatakeyama M, Weinberg RA. The role of RB in cell cycle control. Prog Cell Cycle Res 1995;1:9-19.
31. 1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells. Neoplasia 2004;6:646-59.
32. 1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001;20:2927-36.
33. 1 cell cycle arrest in human umbilical vein endothelial cells by flavone's inhibition of the extracellular signal regulated kinase cascade. Biochem Cell Biol 2004;82:583-8.
34. 1 cell cycle arrest. Oncogene 2004;23:3284-95.
35. Rashid MA, Gustafson KB, Cardellina JH, et al. Brominated chamigrane sesquiterpenoids produce a novel profile of differential cytotoxicity in the NCI in vitro screen. Nat Prod Lett 1995;6:255-9.
36. Juagdan EJ, Kalidinidi R, Scheuer PJ. Two new chamigranes from an Hawaiian red algae, Laurencia cartilaginea. Tetrahedron 1997;53:521-8.
37. Vairappan CS, Suzuki M, Abe T, et al. Halogenated metabolites with antibacterial activity from the Okinawan Laurencia species. Phytochemistry 2001;58:517-23.
38. Konig GM, Wright AD. Laurencia rigida: chemical investigations of its antifouling dichloromethane extract. J Nat Prod 1997;60:967-70.
39. Konig GM, Wright AD, Franzblau SG. Assessment of antimycobacterial activity of a series of mainly marine derived natural products. Planta Med 2000;66:337-42.
40. Copp BR. Antimycobacterial natural products. Nat Prod Rep 2003;20:535-57.
41. Suzuki M, Daitoh M, Vairappan CS, et al. Novel halogenated metabolites from the Malaysian Laurencia pannosa. J Nat Prod 2001;64:597-602.
42. Kimura J, Kamada N, Tsujimoto Y. Fourteen chamigrane derivatives from a red alga, Laurencia nidifica. Bull Chem Soc Jpn 1999;72:289-92.
43. Davyt D, Fernandez R, Suescun L, et al. New sesquiterpene derivatives from the red alga Laurencia scoparia. Isolation, structure determination, and anthelmintic activity. J Nat Prod 2001;64:1552-5.
44. Lahusen T, De Siervi A, Kunick C, et al. Alsterpaullone, a novel cyclin-dependent kinase inhibitor, induces apoptosis by activation of caspase-9 due to perturbation in mitochondrial membrane potential. Mol Carcinog 2003;36:183-94.